文献速递母胎医学

解码22q11.2:丹麦全国队列中的产前特征分析与早孕期风险评估

Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

这项丹麦全国登记队列研究分析了143例胎儿22q11.2缺失或重复妊娠的早孕期联合筛查标志物分布,发现经典重复的筛查标志物模式类似常见三体(PAPP-A降低),而经典缺失则PAPP-A升高,限制了现有筛查算法的早期检出能力。

要点

  • 经典22q11.2缺失胎儿NT均值1.89mm,高于染色体正常参照组1.65mm。
  • 经典缺失组PAPP-A MoM均值1.34,高于参照组1.01;β-hCG MoM均值0.77,低于参照组1.02。
  • 靶向经典缺失的风险算法使产前检出率提高逾一倍,但假阳性率大幅增加。

核心结论

  • 经典22q11.2重复的早孕期联合筛查标志物分布类似常见三体,PAPP-A降低;经典缺失则PAPP-A升高,可能限制现有联合筛查风险算法的早期产前检出。
  • 基于NT、PAPP-A和β-hCG的靶向风险算法改善经典22q11.2缺失早期检出的空间有限。
  • 这体现了联合筛查标志物检测非典型染色体异常的能力与局限,对设计新的产前筛查方案有参考价值。

研究设计与样本

  • 丹麦全国登记队列研究,纳入2008年1月至2018年12月预产期期间接受产前筛查的所有妊娠。
  • 从丹麦细胞遗传学中央登记处检索产前、产后或妊娠丢失/终止后诊断的胎儿22q11.2缺失或重复(hg19 chr22:18.9mio-25.0mio)病例,与丹麦胎儿医学数据库妊娠数据链接。
  • 共纳入143例胎儿22q11.2异常妊娠,其中缺失97例(经典54例),重复46例(经典32例)。
  • 将任意22q11.2缺失或重复(LCR22-A至-H)及经典缺失或重复(LCR22-A至-D)经染色体微阵列诊断的妊娠,与染色体正常参照组比较胎儿及母亲特征、联合筛查结果和妊娠结局。
  • 基于NT、PAPP-A和β-hCG开发评估经典22q11.2缺失个体化风险的风险算法,计算不同风险切点的检出率和假阳性率。

主要发现

  • 经典缺失组NT均值1.89mm,任意缺失组1.78mm,任意重复组1.86mm,均显著高于参照组1.65mm。
  • β-hCG MoM在经典缺失组均值0.77、任意缺失组0.71,均显著低于参照组1.02。
  • PAPP-A MoM在经典重复组均值0.57、任意重复组0.63,显著低于参照组1.01;在经典缺失组均值1.34、任意缺失组1.16,显著高于参照组。
  • 联合筛查筛查阳性率:经典缺失组13.7%、任意缺失组12.5%、经典重复组46.9%、任意重复组37.8%,均显著高于参照组4.5%。
  • 结构畸形检出率:经典缺失组41%、任意缺失组35%、经典重复组17%、任意重复组25%;产前或妊娠丢失后诊断的妊娠丢失率在经典缺失组为40%,经典重复组为5%。

关键数值与推荐

  • 靶向经典22q11.2缺失的风险算法使经典缺失的产前检出率提高逾一倍,但假阳性率大幅增加。
  • 联合筛查标志物在经典重复中呈现类似常见三体的模式(PAPP-A降低),在经典缺失中PAPP-A升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the distribution of nuchal translucency thickness (NT), free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) in pregnancies with a fetal 22q11.2 aberration. Furthermore, the performance of combined first-trimester screening (cFTS) and a new risk algorithm targeting 22q11.2 deletions in detecting affected pregnancies was evaluated. Finally, prenatal malformations and pregnancy outcome were assessed. METHODS: This was a nationwide registry-based cohort study of all pregnancies that underwent prenatal screening with a due date between January 2008 and December 2018 in Denmark. All cases with a fetal 22q11.2 deletion or duplication (hg19 chr22:18.9mio-25.0mio) diagnosed pre- or postnatally or following pregnancy loss or termination of pregnancy were retrieved from the Danish Cytogenetic Central Register and linked with pregnancy data from the Danish Fetal Medicine Database. Fetal and maternal characteristics, including cFTS results and pregnancy outcome, of pregnancies with any 22q11.2 deletion or duplication (LCR22-A to -H) and pregnancies with a classic deletion or duplication (LCR22-A to -D) diagnosed by chromosomal microarray were compared with those of a chromosomally normal reference group. A risk algorithm was developed for assessing patient-specific risks for classic 22q11.2 deletions based on NT, PAPP-A and β-hCG. Detection rates and false-positive rates at different risk cut-offs were calculated. RESULTS: We included data on 143 pregnancies with a fetal 22q11.2 aberration, of which 97 were deletions (54 classic) and 46 were duplications (32 classic). NT was significantly increased in fetuses with a classic deletion (mean, 1.89 mm), those with any deletion (mean, 1.78 mm) and those with any duplication (mean, 1.86 mm) compared to the reference group (mean, 1.65 mm). β-hCG multiples of the median (MoM) was decreased in all 22q11.2 subgroups compared with the reference group (mean, 1.02) and reached significance in pregnancies with a classic deletion and those with any deletion (mean, 0.77 and 0.71, respectively). PAPP-A MoM was significantly decreased in pregnancies with a classic duplication and those with any duplication (mean, 0.57 and 0.63, respectively), and was significantly increased in pregnancies with a classic deletion and those with any deletion (mean, 1.34 and 1.16, respectively), compared to reference pregnancies (mean, 1.01). The screen-positive rate by cFTS was significantly increased in pregnancies with a classic deletion (13.7%), any deletion (12.5%), a classic duplication (46.9%) or any duplication (37.8%) compared to the reference group (4.5%). A risk algorithm targeting classic 22q11.2 deletions more than doubled the prenatal detection rate of classic 22q11.2 deletions, but with a substantial increase in the false-positive rate. Structural malformations were detected in 41%, 35%, 17% and 25% of the pregnancies with a classic deletion, any deletion, classic duplication or any duplication, respectively. Pregnancy loss occurred in 40% of pregnancies with a classic deletion and 5% of those with a classic duplication diagnosed prenatally or following pregnancy loss. CONCLUSIONS: The distribution of cFTS markers in pregnancies with a classic 22q11.2 duplication resembles that of the common trisomies, with decreased levels of PAPP-A. However, classic 22q11.2 deletions are associated with increased levels of PAPP-A, which likely limits early prenatal detection using the current cFTS risk algorithm. The scope for improving early detection of classic 22q11.2 deletions using targeted risk algorithms based on NT, PAPP-A and β-hCG is limited. This demonstrates the capability, but also the limitations, of cFTS markers in detecting atypical chromosomal anomalies, which is important knowledge when designing new prenatal screening programs. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gadsbøll K, Vogel I, Pedersen LH, et al. Decoding 22q11.2: prenatal profiling and first-trimester risk assessment in Danish nationwide cohort. Ultrasound Obstet Gynecol. 2024. PMID: 37643358. doi:10.1002/uog.27466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。